In: Accounting
a. Please provide a paragrpah (so that is sentences of three or more sentences in the specifed areas mentioned below) of the Finacial Ratio Analysis for CVS and Walgreens. Please include the Current Ratio vs the Acid Test ratio, the Days sales in inventory vs. the inventory turn over in Days and the Days Sales in receivable vs. Accounts receivable turn over in days.
CVS
Balance Sheet
All numbers in thousands
Period Ending |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Current Assets |
|||
Cash And Cash Equivalents |
1,696,000 |
3,371,000 |
2,459,000 |
Short Term Investments |
111,000 |
87,000 |
88,000 |
Net Receivables |
13,181,000 |
12,164,000 |
11,888,000 |
Inventory |
15,296,000 |
14,760,000 |
14,001,000 |
Other Current Assets |
945,000 |
660,000 |
722,000 |
Total Current Assets |
31,229,000 |
31,042,000 |
29,158,000 |
Long Term Investments |
- |
- |
- |
Property Plant and Equipment |
10,292,000 |
10,175,000 |
9,855,000 |
Goodwill |
38,451,000 |
38,249,000 |
38,106,000 |
Intangible Assets |
13,630,000 |
13,511,000 |
13,878,000 |
Accumulated Amortization |
- |
- |
- |
Other Assets |
1,529,000 |
1,485,000 |
1,440,000 |
Deferred Long Term Asset Charges |
- |
- |
- |
Total Assets |
95,131,000 |
94,462,000 |
92,437,000 |
Current Liabilities |
|||
Accounts Payable |
15,472,000 |
14,883,000 |
14,319,000 |
Short/Current Long Term Debt |
15,176,000 |
11,367,000 |
8,850,000 |
Other Current Liabilities |
- |
- |
- |
Total Current Liabilities |
30,648,000 |
26,250,000 |
23,169,000 |
Long Term Debt |
22,181,000 |
25,615,000 |
26,267,000 |
Other Liabilities |
1,611,000 |
1,549,000 |
1,542,000 |
Deferred Long Term Liability Charges |
2,996,000 |
4,214,000 |
4,217,000 |
Minority Interest |
4,000 |
4,000 |
7,000 |
Negative Goodwill |
- |
- |
- |
Total Liabilities |
57,440,000 |
57,632,000 |
55,202,000 |
Stockholders' Equity |
|||
Misc. Stocks Options Warrants |
- |
- |
39,000 |
Redeemable Preferred Stock |
- |
- |
- |
Preferred Stock |
- |
- |
- |
Common Stock |
17,000 |
17,000 |
17,000 |
Retained Earnings |
43,556,000 |
38,983,000 |
35,506,000 |
Treasury Stock |
-37,765,000 |
-33,452,000 |
-28,886,000 |
Capital Surplus |
32,079,000 |
31,618,000 |
30,948,000 |
Other Stockholder Equity |
-196,000 |
-336,000 |
-389,000 |
Total Stockholder Equity |
37,691,000 |
36,830,000 |
37,196,000 |
Net Tangible Assets |
-14,390,000 |
-14,930,000 |
-14,788,000 |
Income Statement
All numbers in thousands
Revenue |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Total Revenue |
184,765,000 |
177,526,000 |
153,290,000 |
Cost of Revenue |
156,220,000 |
148,669,000 |
126,762,000 |
Gross Profit |
28,545,000 |
28,857,000 |
26,528,000 |
Operating Expenses |
|||
Research Development |
- |
- |
- |
Selling General and Administrative |
- |
- |
- |
Non Recurring |
- |
- |
- |
Others |
- |
- |
- |
Total Operating Expenses |
- |
- |
- |
Operating Income or Loss |
9,517,000 |
10,366,000 |
9,475,000 |
Income from Continuing Operations |
|||
Total Other Income/Expenses Net |
-208,000 |
-671,000 |
-21,000 |
Earnings Before Interest and Taxes |
9,309,000 |
9,695,000 |
9,454,000 |
Interest Expense |
1,041,000 |
1,058,000 |
838,000 |
Income Before Tax |
8,268,000 |
8,637,000 |
8,616,000 |
Income Tax Expense |
1,637,000 |
3,317,000 |
3,386,000 |
Minority Interest |
4,000 |
4,000 |
7,000 |
Net Income From Continuing Ops |
6,631,000 |
5,320,000 |
5,230,000 |
Non-recurring Events |
|||
Discontinued Operations |
-8,000 |
-1,000 |
9,000 |
Extraordinary Items |
- |
- |
- |
Effect Of Accounting Changes |
- |
- |
- |
Other Items |
- |
- |
- |
Net Income |
|||
Net Income |
6,622,000 |
5,317,000 |
5,237,000 |
Preferred Stock And Other Adjustments |
- |
- |
- |
Net Income Applicable To Common Shares |
6,622,000 |
5,317,000 |
5,237,000 |
Walgreens
Income Statement
All numbers in thousands
Revenue |
8/31/2017 |
8/31/2016 |
8/31/2015 |
Total Revenue |
118,214,000 |
117,351,000 |
103,444,000 |
Cost of Revenue |
89,052,000 |
87,477,000 |
76,691,000 |
Gross Profit |
29,162,000 |
29,874,000 |
26,753,000 |
Operating Expenses |
|||
Research Development |
- |
- |
- |
Selling General and Administrative |
23,605,000 |
23,873,000 |
22,085,000 |
Non Recurring |
- |
- |
- |
Others |
- |
- |
- |
Total Operating Expenses |
- |
- |
- |
Operating Income or Loss |
5,557,000 |
6,001,000 |
4,668,000 |
Income from Continuing Operations |
|||
Total Other Income/Expenses Net |
-11,000 |
-261,000 |
1,248,000 |
Earnings Before Interest and Taxes |
5,546,000 |
5,740,000 |
5,916,000 |
Interest Expense |
693,000 |
596,000 |
605,000 |
Income Before Tax |
4,853,000 |
5,144,000 |
5,311,000 |
Income Tax Expense |
752,000 |
953,000 |
1,032,000 |
Minority Interest |
808,000 |
401,000 |
439,000 |
Net Income From Continuing Ops |
4,078,000 |
4,173,000 |
4,220,000 |
Non-recurring Events |
|||
Discontinued Operations |
- |
- |
- |
Extraordinary Items |
- |
- |
- |
Effect Of Accounting Changes |
- |
- |
- |
Other Items |
- |
- |
- |
Net Income |
|||
Net Income |
4,078,000 |
4,173,000 |
4,220,000 |
Preferred Stock And Other Adjustments |
- |
- |
- |
Net Income Applicable To Common Shares |
4,078,000 |
4,173,000 |
4,220,000 |
Balance Sheet
All numbers in thousands
Period Ending |
8/31/2017 |
8/31/2016 |
8/31/2015 |
Current Assets |
|||
Cash And Cash Equivalents |
3,301,000 |
9,807,000 |
3,000,000 |
Short Term Investments |
- |
- |
- |
Net Receivables |
6,528,000 |
6,260,000 |
6,849,000 |
Inventory |
8,899,000 |
8,956,000 |
8,678,000 |
Other Current Assets |
1,025,000 |
860,000 |
1,130,000 |
Total Current Assets |
19,753,000 |
25,883,000 |
19,657,000 |
Long Term Investments |
6,320,000 |
6,174,000 |
1,242,000 |
Property Plant and Equipment |
13,642,000 |
14,335,000 |
15,068,000 |
Goodwill |
15,632,000 |
15,527,000 |
16,372,000 |
Intangible Assets |
10,156,000 |
10,302,000 |
12,351,000 |
Accumulated Amortization |
- |
- |
- |
Other Assets |
506,000 |
467,000 |
4,092,000 |
Deferred Long Term Asset Charges |
- |
- |
- |
Total Assets |
66,009,000 |
72,688,000 |
68,782,000 |
Current Liabilities |
|||
Accounts Payable |
18,296,000 |
16,690,000 |
15,489,000 |
Short/Current Long Term Debt |
251,000 |
323,000 |
1,068,000 |
Other Current Liabilities |
- |
- |
- |
Total Current Liabilities |
18,547,000 |
17,013,000 |
16,557,000 |
Long Term Debt |
12,684,000 |
18,705,000 |
13,315,000 |
Other Liabilities |
4,223,000 |
4,045,000 |
4,072,000 |
Deferred Long Term Liability Charges |
2,281,000 |
2,644,000 |
3,538,000 |
Minority Interest |
808,000 |
401,000 |
439,000 |
Negative Goodwill |
- |
- |
- |
Total Liabilities |
37,735,000 |
42,407,000 |
37,482,000 |
Stockholders' Equity |
|||
Misc. Stocks Options Warrants |
- |
- |
- |
Redeemable Preferred Stock |
- |
- |
- |
Preferred Stock |
- |
- |
- |
Common Stock |
12,000 |
12,000 |
12,000 |
Retained Earnings |
30,137,000 |
27,684,000 |
25,089,000 |
Treasury Stock |
-9,971,000 |
-4,934,000 |
-3,977,000 |
Capital Surplus |
10,339,000 |
10,111,000 |
9,953,000 |
Other Stockholder Equity |
-3,051,000 |
-2,993,000 |
-216,000 |
Total Stockholder Equity |
27,466,000 |
29,880,000 |
30,861,000 |
Net Tangible Assets |
1,678,000 |
4,051,000 |
2,138,000 |